Russian pharmaceutical company R-Pharm is working to retool rheumatoid arthritis drug, olokizumab, to treat COVID-19 patients with moderate to severe infections, its Chief Medical Officer Mikhail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback